Product Details

Apo-Dutasteride

Dutasteride
0.5 mg
Capsule


DIN/PIN/NPN

02404206

Manufacturer

Apotex Inc.

Formulary Listing Date

2014-09-25  

Unit Price

0.2565

Amount MOH Pays

0.2565

Coverage Status

Limited Use Product Chronic-Use Medication

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

G04CB02

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02490587 Priva-Dutasteride 0.2565 0.2565
02408287 Teva-Dutasteride 0.2565 0.2565
02424444 Sandoz Dutasteride 0.2565 0.2565
02393220 PMS-Dutasteride 0.2565 0.2565
02428873 Mint-Dutasteride 0.2565 0.2565
02416298 Med-Dutasteride 0.2565 0.2565
02484870 Jamp Dutasteride 0.2565 0.2565
02443058 Dutasteride 0.2565 0.2565
02429012 Dutasteride 0.2565 0.2565
02247813 Avodart 2.1070 0.2565
02469308 Auro-Dutasteride 0.2565 0.2565
02404206 Apo-Dutasteride 0.2565 0.2565
 

LU Clinical Criteria

LU Code Auth. Period Clinical Criteria
384 Indefinite

For use in combination with an alpha blocker for the treatment of men with symptomatic* Benign Prostatic Hyperplasia.

*Symptomatic is defined as having moderate (about half the time) to severe (almost always) symptoms related to the prostate in at least 4 of the following domains:
1. feeling of incomplete emptying of the bladder after voiding
2. needing to urinate again less than 2 hours after previous void
3. stopping and starting urine several times while voiding
4. difficulty postponing urination
5. weak urinary stream
6. pushing or straining to begin voiding
7. the need to get up to void at least 3 times in the night.

385 Indefinite

For monotherapy, as a second line agent in patients with symptomatic* Benign Prostatic Hyperplasia following treatment failure or intolerance to an alpha blocker.

*Symptomatic is defined as having moderate (about half the time) to severe (almost always) symptoms related to the prostate in at least 4 of the following domains:
1. feeling of incomplete emptying of the bladder after voiding
2. needing to urinate again less than 2 hours after previous void
3. stopping and starting urine several times while voiding
4. difficulty postponing urination
5. weak urinary stream
6. pushing or straining to begin voiding
7. the need to get up to void at least 3 times in the night.

 

EAP Criteria

NO

Product Monograph

View Monograph